Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
PMC2930015 7
Novo Nordisk is the market leader: Ozempic (weekly injection for type 2 diabetes) Wegovy (higher-dose weekly injection for obesity) Rybelsus ( Oral tablets for diabetes Oral tablets for weight management is in phase 3 trials) Eli Lilly is the other major player: Mounjaro (weekly injection for type 2 diabetes) Zepbound (higherdose weekly injection for obesity) This duopoly meant that both stocks had an incredible run-up from 2020 to 2024
71% of GLP-1 users are buying more high-protein foods, per Chicory's 2026 GLP-1 Survey
(1986) 29:549A
US$ 25.32
US$ 26.97
US$ 20.48
US$ 22.14
US$ 26.24
